The Bull Rankings scorecard — our quality-growth score is 73.7 / 100, built from three pillars each graded 0–100 against sector peers: Quality 66, Growth 81, Value 74. At today's price, our reverse-DCF read says the market is implicitly betting on about 21% a year in free-cash-flow growth sustained for a decade — a gauge of how much optimism is already in the stock.
The thesis
Ingersoll Rand’s stock is betting on growth that outpaces its engine. At a PE of 34.5 and a PEG of 0.81, the market rewards the 7.8% FY revenue expansion with a sub‑1.0 valuation multiple. Our model’s Quality‑Growth score of 73.7 tells a mixed story: the Growth pillar (81) is the engine, while Quality (66) is the weak link. The reverse‑DCF shows today’s $83.38 share implying ~21% free‑cash‑flow growth for ten years—far above the 7.8% top‑line pace. That gap signals optimism baked into the price; the stock is therefore overvalued relative to its sustainable growth.
What the business actually is
Ingersoll Rand delivers mission‑critical air, fluid, clean‑energy and medical technologies worldwide. Its Industrial Technologies and Services segment designs and manufactures air‑ and gas‑compression gear, vacuum and blower units, fluid‑transfer equipment, loading systems, power tools and lifting gear. It also sells aftermarket parts, consumables, air‑treatment controls and related services under the Ingersoll Rand and Gardner Denver brands. The Precision and Science Technologies side focuses on high‑precision instruments for scientific and medical markets, but the bulk of revenue growth comes from the industrial compression and fluid‑handling portfolio that serves factories, construction sites and OEMs.
Why it can keep compounding
The company’s 12.1% profit margin and ROE of 9.4% indicate decent, if not spectacular, returns on capital. The real moat lies in the aftermarket ecosystem: compressors and blowers have long service lives, and customers rely on OEM‑approved parts and service contracts that lock in recurring revenue. Competitors can sell a unit, but they cannot instantly replicate the installed‑base of service agreements and the deep engineering expertise required to keep critical air‑system uptime high. Our model flags a “Buying back stock” signal, suggesting management believes the balance sheet can fund repurchases without jeopardising growth initiatives. That capital return discipline reinforces cash‑flow generation, giving the firm a lever to boost EPS even if organic growth stalls.
The valuation question
A price‑to‑sales of 4.1 and a market cap of $32.6b sit comfortably above the sector median, reflecting the premium placed on the growth narrative. Yet the reverse‑DCF’s implied 21% FCF CAGR dwarfs the 7.8% FY revenue growth and the modest 9.4% ROE. In other words, the market is assuming the company will dramatically accelerate cash‑flow conversion or expand margins far beyond current levels. The PEG of 0.81 masks this optimism because it divides the PE by growth, but it does not capture the gap between cash‑flow expectations and realistic earnings expansion. With a beta of 1.17, the stock is also more volatile than the market, meaning the upside premium is priced in alongside higher risk. The consensus 1‑year target of $93.64 implies an 11.9% upside, but that target already embeds the 21% FCF growth assumption. If the firm can’t lift cash flow that sharply, the price will struggle to justify its multiple.
The bear case
The weakest pillar—Quality at 66—signals that the business’s fundamentals are not as robust as its growth story suggests. A debt‑to‑equity of 0.47 is modest, but the profit margin of 12.1% leaves limited cushion if input costs rise or pricing pressure intensifies, especially given recent margin pressure reported from China. The Q2 earnings call in late July highlighted that “margin pressure from China” is already eroding profitability. Should those pressures persist, the company’s cash‑flow generation could fall short of the 21% trajectory, forcing a multiple contraction. A decisive bearish trigger would be a quarterly EPS miss coupled with a downward revision of the full‑year revenue outlook—the kind of signal that would validate the Quality weakness.
What would change our mind
First, a sustained free‑cash‑flow growth rate approaching 21% over the next two quarters would bridge the gap between the reverse‑DCF assumption and reality, vindicating the current premium. Second, an improvement in the Quality pillar—say, a margin lift to 12.1% or a ROE climbing above 9.4%—would demonstrate that the business can generate higher returns on its capital, making the 21% cash‑flow growth plausible. Third, a clear, credible reduction in margin pressure from China, evidenced by a revised guidance that lifts the FY revenue outlook while holding margins steady, would neutralize the Quality concern and justify the growth premium. Until one of those conditions materializes, the price remains stretched relative to the fundamentals we see.